ArticlePloS one2018

Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.

Angelos Koutras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.